Mylan shares surge after FDA approves its generic multiple sclerosis treatment
October 04, 2017 at 08:04 AM EDT
The approvals "mark another significant milestone for our company," Mylan CEO Heather Bresch says.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.